
Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia
Keywords: NICCD, neonatal intrahepatic cholestasis; CTLN2, adult-onset type II citrullinemia; MCT, medium-chain triglycerides; ASS1, argininosuccinate synthetase 1; ALT, alanine aminotransferase; γ-GTP, gamma-glutamyl transpeptidase; PSTI, pancreatic secretory tryp